Viveve Medical, Inc. Watch

from S-1/A 38 pages Underwriting Agreement Between Viveve Medical, Inc. and A.G.P./ALLIANCE Global Partners, as Representative of the Several Underwriters Viveve Medical, Inc. Underwriting Agreement

from S-1/A 38 pages Underwriting Agreement Between Viveve Medical, Inc. and A.G.P./ALLIANCE Global Partners, as Representative of the Several Underwriters Viveve Medical, Inc. Underwriting Agreement

from SC 13G/A 2 pages Joint Filing Statement Pursuant to Rule 13d-1

from S-1/A 41 pages Shares of Common Stock, Shares of Series a Convertible Preferred Stock (Convertible Into Shares of Common Stock), and Warrants (Exercisable for Shares of Common Stock) of Viveve Medical, Inc. Underwriting Agreement

from S-1/A 41 pages Shares of Common Stock, Shares of Series a Convertible Preferred Stock (Convertible Into Shares of Common Stock), and Warrants (Exercisable for Shares of Common Stock) of Viveve Medical, Inc. Underwriting Agreement

from 8-K 33 pages Viveve Medical, Inc. $6,760,000 Common Stock Sales Agreement

from SC 13G/A 2 pages Joint Filing Statement Pursuant to Rule 13d-1

from 8-K 41 pages 13,333,334 Shares Viveve Medical, Inc. Common Stock Underwriting Agreement

from SC 13G/A 2 pages Joint Filing Statement Pursuant to Rule 13d-1

from 8-K 41 pages 10,000,000 Shares Viveve Medical, Inc. Common Stock Underwriting Agreement

from S-3 31 pages Viveve Medical, Inc. $25,000,000 Common Stock Sales Agreement

from S-1/A 41 pages [Number of Shares] Viveve Medical, Inc. Common Stock Underwriting Agreement

from SC 13G/A 2 pages Joint Filing Statement Pursuant to Rule 13d-1

from 8-K 39 pages 2,700,000 Shares of Common Stock Viveve Medical, Inc. Underwriting Agreement June 14, 2016

from S-1/A 39 pages Shares of Common Stock Viveve Medical, Inc. Underwriting Agreement June __, 2016

from SC 13G/A 2 pages Joint Filing Statement Pursuant to Rule 13d-1

from SC 13G 1 page Exhibit 1 Joint Filing Statement Statement Pursuant to Rule 13d-1(k)(1) the Undersigned Hereby Consent and Agree to File a Joint Statement on Schedule 13g Under the Securities Exchange Act of 1934, as Amended, With Respect to the Common Stock, $.01 Par Value, of Viveve Medical, Inc. Beneficially Owned by Them, Together With Any or All Amendments Thereto, When and if Appropriate. the Parties Hereto Further Consent and Agree to File This Statement Pursuant to Rule 13d-1(k)(1)(iii) as an Exhibit to Schedule 13g,thereby Incorporating the Same Into Such Schedule 13g. Dated: October 1, 2015 Rtw Investments, LLC By: /S/ Roderick Wong Roderick Wong, Managing Member Rtw Master Fund, Ltd. By: /S/ Roderick Wong Roderick Wong, Managing Member

from SC 13D ~20 pages Underwriting agreement